Results 191 to 200 of about 56,990 (293)

Hormonal Contraception, Menstrual Cycle Characteristics, and Lower Limb Injuries in Elite Female Team Sports-Identifying Factors Associated With Increased Injury Prevalence: A Cross-Sectional Study. [PDF]

Health Sci Rep
Kirschbaum EM, Henke J, Heyde K, Legerlotz K.   +3 more
europepmc   +1 more source

Targeting inflammation in cardiometabolic disease: Icosapent ethyl modulates monocyte‐derived macrophages isolated from patients with cardiovascular disease with or without type 2 diabetes

Diabetic Medicine, Volume 43, Issue 4, April 2026.
Abstract Aims Despite intensive lipid‐lowering therapy, individuals with atherosclerotic cardiovascular disease (ASCVD) exhibit residual inflammatory risk, which drives recurrent cardiovascular events. This risk is amplified in type 2 diabetes mellitus (T2DM), where a pro‐inflammatory milieu accelerates atherogenesis. Monocyte‐derived macrophages (MDMs)
J. K. Ward, M. U. Shah, K. Lee, P. E. Squires, C. E. Hills   +4 more
wiley   +1 more source

No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study. [PDF]

Front Immunol
Young MR, Mehta CC, Staple T, Herring GB, Govindaraj S, Ibegbu C, Herold BC, Velu V, Haddad LB, Smith AK.   +9 more
europepmc   +1 more source

Women's Care in First‐Episode Psychosis: Clinicians' Perspectives on Service Provision

Early Intervention in Psychiatry, Volume 20, Issue 4, April 2026.
ABSTRACT Background Early intervention in Psychosis (EIP) services are vital in reducing the long‐term impact of first‐episode psychosis (FEP). However, women with FEP encounter unique biological, social, and systemic challenges that may delay diagnosis, hinder access to care, and affect treatment engagement.
Grainne McGinty, Sean Naughton, Keith Gaynor, Saoirse Byrne, Roisin Farrelly, Anja Stano, Mary Clarke   +6 more
wiley   +1 more source

Risk of fracture in users of hormonal contraception. [PDF]

Cochrane Database Syst Rev
Ramanadhan S, Henderson JT, Cantor A, Paynter RA, Edelman A.   +4 more
europepmc   +1 more source

A Linacre Institute Paper: Rape Protocol [PDF]

, 1993
Diamond, Eugene F.
core   +1 more source

Care Pathways and Determinants in Essure® Contraceptive Implant Use and Removal: A Qualitative Study

Health Expectations, Volume 29, Issue 2, April 2026.
ABSTRACT Background Introduced in 2002, the Essure® implant was promoted as a minimally invasive permanent contraceptive. After widespread use, increasing reports of adverse effects led to its global withdrawal in 2018. This study explores the experiences of women in France who chose Essure®, focusing on their motivations and the factors leading to its
Jéronine Tengue, Adeline Darlington‐Bernard, Titouan Michon, Nathalie Bernoud‐Hubac, Benoit Ter‐Ovanessian, Ana‐Maria Trunfio‐Sfarghiu, Claude Dussart, Romain Lan, Florence Carrouel   +8 more
wiley   +1 more source

Are Body Composition Estimates Affected by the Menstrual Cycle in Females With or Without Hormonal Contraception?-A Case-Control Study. [PDF]

Eur J Sport Sci
Stein-Brüggemann D, Schultz L, Kiefer KM, Fürst J, Reer R, Schröder J.   +5 more
europepmc   +1 more source

Trichoscopic Evaluation of the Effectiveness of Topical Stemoxydine for Hair Restoration in Androgenetic Alopecia: A Prospective Pre–Post Single‐Arm Exploratory Study

Journal of Cosmetic Dermatology, Volume 25, Issue 4, April 2026.
ABSTRACT Background Androgenetic Alopecia (AGA) is a prevalent hereditary disorder leading to hair loss. Stemoxydine, a competitive (Prolyl 4‐hydroxylase) inhibitor, may activate Hypoxia‐Inducible Factor 1‐alpha signaling and shorten the hair kenogen phase, potentially increasing hair density as a proposed treatment for AGA.
Yasmina Ahmed Elattar, Noha Nabil Doghem, Mai Tarek Amin, Soha Abdalla Hawwam   +3 more
wiley   +1 more source

Arterial Hypertension and its Impact on the Prescription of Combined Hormonal Contraception. [PDF]

Mater Sociomed
Legan M, Dezman LV, Kokol NL, Mlinaric M.   +3 more
europepmc   +1 more source